These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28719795)

  • 1. Estimating the Direct Medical Economic Burden of Health Care-Associated Infections in Public Tertiary Hospitals in Hubei Province, China.
    Li H; Liu X; Cui D; Wang Q; Mao Z; Fang L; Zhang F; Yang P; Wu H; Ren N; He J; Sun J
    Asia Pac J Public Health; 2017 Jul; 29(5):440-450. PubMed ID: 28719795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct medical burden of antimicrobial-resistant healthcare-associated infections: empirical evidence from China.
    Liu X; Cui D; Li H; Wang Q; Mao Z; Fang L; Ren N; Sun J
    J Hosp Infect; 2020 Jun; 105(2):295-305. PubMed ID: 31931043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospitalization costs due to healthcare-associated infections: An analysis of propensity score matching.
    Lv Y; Chen L; Yu J W; Xiang Q; Tang QS; Wang FD; Cai HM; Zou K; Wei QD; Zhou HZ; Wang H; Wang C; Chen J; Li TL; Fang Y; Wang H
    J Infect Public Health; 2019; 12(4):568-575. PubMed ID: 30824329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-center nested case-control study on hospitalization costs and length of stay due to healthcare-associated infection.
    Lü Y; Cai MH; Cheng J; Zou K; Xiang Q; Wu JY; Wei DQ; Zhou ZH; Wang H; Wang C; Chen J
    Antimicrob Resist Infect Control; 2018; 7():99. PubMed ID: 30116526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital-acquired infections in Belgian acute-care hospitals: financial burden of disease and potential cost savings.
    Trybou J; Spaepen E; Vermeulen B; Porrez L; Annemans L
    Acta Clin Belg; 2013; 68(3):199-205. PubMed ID: 24156220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of healthcare-associated infections to the Brazilian public Unified Health System in a tertiary-care teaching hospital: a matched case-control study.
    Osme SF; Almeida APS; Lemes MF; Barbosa WO; Arantes A; Mendes-Rodrigues C; Gontijo Filho PP; Ribas RM
    J Hosp Infect; 2020 Oct; 106(2):303-310. PubMed ID: 32693085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden attributable to hospital-acquired infections among tumor patients from a large regional cancer center in Southern China.
    Huang L; Ning H; Liu XC; Wang Y; Deng C; Li H
    Am J Infect Control; 2024 Aug; 52(8):934-940. PubMed ID: 38460730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-acquired lower respiratory tract infections among high risk hospitalized patients in a tertiary care teaching hospital in China: An economic burden analysis.
    Yan T; Li Y; Sun Y; Wang H; Wang J; Wang W; Liu Y; Wu X; Wang S
    J Infect Public Health; 2018; 11(4):507-513. PubMed ID: 29113779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and meta-analysis of disease burden of healthcare-associated infections in China: an economic burden perspective from general hospitals.
    Liu X; Spencer A; Long Y; Greenhalgh C; Steeg S; Verma A
    J Hosp Infect; 2022 May; 123():1-11. PubMed ID: 35182684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a framework for identifying risk factors and estimating direct economic disease burden attributable to healthcare-associated infections: a case study of a Chinese Tuberculosis hospital.
    Ren N; Liu X; Luo Y; Li G; Huang Y; Ji D; Peng C; Sun J; Li H
    Glob Health Res Policy; 2024 Sep; 9(1):33. PubMed ID: 39252124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study.
    Su LH; Chen IL; Tang YF; Lee JS; Liu JW
    PLoS One; 2020; 15(5):e0233265. PubMed ID: 32421700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New evidence on supplier-induced demand in China's public tertiary hospitals: is the cost of hospitalization higher in the off-season?
    Shen C; Deng Q; Lai S; Yang L; Zhao D; Zhao Y; Zhou Z
    Eur J Health Econ; 2024 Aug; 25(6):951-962. PubMed ID: 37922094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.
    Cassini A; Plachouras D; Eckmanns T; Abu Sin M; Blank HP; Ducomble T; Haller S; Harder T; Klingeberg A; Sixtensson M; Velasco E; Weiß B; Kramarz P; Monnet DL; Kretzschmar ME; Suetens C
    PLoS Med; 2016 Oct; 13(10):e1002150. PubMed ID: 27755545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
    Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and Economic Insights into Parkinson's Disease Hospitalization: A Comprehensive Study of 19,719 Inpatient Cases in Hubei Province, China.
    Liu W; Nie P; Zhang J; Zhou D; Zhang J; Chen J
    Neuroepidemiology; 2024; 58(4):237-246. PubMed ID: 38290491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic burden attributable to healthcare-associated infections at western China hospitals: 6 Year, prospective cohort study.
    Lv Y; Huang X; Wu J; Xiao X; Ma C; Jiang X; Zhou P; Liu L; Jiang Y; Zou A; Niu H; Sun J; Hou L; Wang X; Dai Y; Peng S; Deng X; Xia H; Guo Y; Wang D; Huang T; Li C; He L; Xiong F; Xiong H; Cao H; Lu J; Liu X; Jian X; Luo W; An Y; Wu Y; Deng K; Kang X; Chen X; Tang B; Li L; Xiang Q
    J Infect; 2024 Feb; 88(2):112-122. PubMed ID: 38135161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods.
    Roberts RR; Scott RD; Hota B; Kampe LM; Abbasi F; Schabowski S; Ahmad I; Ciavarella GG; Cordell R; Solomon SL; Hagtvedt R; Weinstein RA
    Med Care; 2010 Nov; 48(11):1026-35. PubMed ID: 20940650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the direct cost of heart failure hospitalization in a public tertiary hospital.
    Parissis J; Athanasakis K; Farmakis D; Boubouchairopoulou N; Mareti C; Bistola V; Ikonomidis I; Kyriopoulos J; Filippatos G; Lekakis J
    Int J Cardiol; 2015 Feb; 180():46-9. PubMed ID: 25438208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct medical economic burden of healthcare-associated infections and antimicrobial resistance: A preliminary study in a teaching hospital of Nepal.
    Liu X; Shrestha R; Koju P; Maharjan B; Shah P; Thapa P; Li H
    J Glob Antimicrob Resist; 2022 Jun; 29():299-303. PubMed ID: 35483612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.